Results 61 to 70 of about 112,020 (111)

Oncosexology: A Narrative Review on Sexual Health and Quality of Life in Cancer Patients

open access: yesCancer Medicine, Volume 15, Issue 4, April 2026.
ABSTRACT Cancer remains a major global public health problem. A key aspect of cancer care among survivors is sexual health. Cancer patients experience a range of sexual dysfunctions, including erectile dysfunction, vaginal dryness, dyspareunia, and reduced libido.
Pasquale Marino   +8 more
wiley   +1 more source

Vulvovaginal atrophy in women with and without a history of breast cancer: Baseline data from the PatiEnt satisfactiON studY (PEONY) in Italy [PDF]

open access: yes
Objectives: To assess clinical characteristics of postmenopausal women with moderate/severe vulvovaginal atrophy, as well as its impact on sexual function, well-being, and quality of life, and to provide an overview of most used treatments. Study design:
Salvatore, Stefano   +7 more
core   +4 more sources

Efficacy and safety of fractional microablative radiofrequency versus topical estriol in treating genitourinary syndrome of menopause: A pilot study

open access: yesInternational Journal of Gynecology &Obstetrics, Volume 173, Issue 1, Page 521-524, April 2026.
Abstract Objective To compare the efficacy and safety of fractional microablative radiofrequency (RF) and topical estriol in the treatment of genitourinary syndrome of menopause (GSM). Methods This pilot randomized controlled trial included 30 healthy postmenopausal women with GSM.
Priscila de Almeida Torre   +6 more
wiley   +1 more source

Laser and radiofrequency for treating genitourinary syndrome of menopause in breast cancer survivors: A systematic review of randomized controlled trial

open access: yesInternational Journal of Gynecology &Obstetrics, Volume 173, Issue 1, Page 99-108, April 2026.
Abstract Background Breast cancer survivors (BCS) often experience more severe symptoms of genitourinary syndrome of menopause (GSM). As estrogen‐based hormonal therapy is generally avoided in BCS, physical energy methods may offer promising non‐hormonal alternatives.
Nicoli Serquiz   +7 more
wiley   +1 more source

Clinical case: patient treated for vulvovaginal candidiasis

open access: yes, 2021
Case study of acute vulvovaginal candidiasis treated with medication containing dequalinium chloride as an active ingredient has been reported. Patient A.
Tatyana Yu. Pestrikova
core   +1 more source

Evidence‐ and consensus‐based guideline on lichen sclerosus

open access: yesJDDG: Journal der Deutschen Dermatologischen Gesellschaft, Volume 24, Issue 4, Page 566-584, April 2026.
Summary The German‐language, consensus‐ and evidence‐based S3 guideline on lichen sclerosus (LS) was developed based on the European “EuroGuiDerm Guideline on lichen sclerosus” under the leadership of the German Dermatological Society (DDG) and the German Society for Gynecology and Obstetrics (DGGG).
Gudula Kirtschig   +25 more
wiley   +1 more source

Cerebral atrophy in mild cognitive impairment and Alzheimer disease: rates and acceleration. [PDF]

open access: yes, 2013
OBJECTIVE: To quantify the regional and global cerebral atrophy rates and assess acceleration rates in healthy controls, subjects with mild cognitive impairment (MCI), and subjects with mild Alzheimer disease (AD).
Manning, Emily N   +16 more
core   +1 more source

Elasticity Improvement and Water Loss Prevention in Vulvar Skin by Topical Nonhormonal Moisturizer

open access: yesJEADV Clinical Practice, Volume 5, Issue 1, Page 117-123, March 2026.
Effect of topical non‐hormonal moisturizer on the vulva in postmenopausal women. Moisturizer is completely absorbed. Water loss from vulva is reduced by 51% compared to baseline measurements. Elasticity is improved by 21% compared to baseline measurements.
Hans Christian Wulf   +2 more
wiley   +1 more source

Carbon dioxide laser treatment for vulvovaginal atrophy in women treated for breast cancer: Preliminary results of the feasibility EPIONE trial

open access: yes, 2020
International audienceBackground and objective: Quality of life preservation after anti-cancer therapy is a major challenge for breast cancer survivors. Approximately 42-70% of patients who receive systemic therapy for breast cancer, including endocrine ...
Kalsoum, S.   +9 more
core   +1 more source

Home - About - Disclaimer - Privacy